Effects	NNS	effect NNS PennPOS
and	CC	and cc NUPOS
mechanisms	NNS	mechanism NNS PennPOS
of	IN	of pp-f NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
,	,	, , NUPOS
prednisone	NN	prednisone NN PennPOS
and	CC	and cc NUPOS
acetylcysteine	NN	acetylcysteine NN PennPOS
on	IN	on IN PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
in	IN	in IN PennPOS
rat	NN	rat NN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
models	NNS	model NNS PennPOS
.	.	. . NUPOS

CONTEXT	NNP	context NN PennPOS
:	:	: : NUPOS
Previous	JJ	previous JJ PennPOS
studies	NNS	study NNS PennPOS
have	VBP	have vhb NUPOS
reported	VBN	report VBN PennPOS
that	IN	that cst NUPOS
caveolin-1	NN	caveolin-1 NN PennPOS
(	(	( ( NUPOS
Cav-1	NN	Cav-1 NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

However	RB	however a-acp NUPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
role	NN	role NN PennPOS
of	IN	of pp-f NUPOS
Cav-1	NN	Cav-1 NN PennPOS
expression	NN	expression NN PennPOS
in	IN	in IN PennPOS
pirfenidone-treated	JJ	pirfenidone-treated JJ PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
unknown	JJ	unknown JJ PennPOS
.	.	. . NUPOS

OBJECTIVE	NN	objective NN PennPOS
:	:	: : NUPOS
This	DT	this d NUPOS
study	NN	study NN PennPOS
investigated	VBD	investigate VBD PennPOS
Cav-1	NN	Cav-1 NN PennPOS
expression	NN	expression NN PennPOS
in	IN	in IN PennPOS
pirfenidone-treated	JJ	pirfenidone-treated JJ PennPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
compared	VBD	compare VBD PennPOS
the	DT	the dt NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
with	IN	with pp NUPOS
acetylcysteine	NN	acetylcysteine NN PennPOS
and	CC	and cc NUPOS
prednisone	NN	prednisone NN PennPOS
on	IN	on IN PennPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

MATERIALS	NNS	material NNS PennPOS
AND	CC	and cc NUPOS
METHODS	NNS	method NNS PennPOS
:	:	: : NUPOS
Rat	NN	rat NN PennPOS
IPF	NN	IPF NN PennPOS
model	NN	model NN PennPOS
was	VBD	be vbd NUPOS
established	VBN	establish VBN PennPOS
by	IN	by IN PennPOS
endotracheal	JJ	endotracheal JJ PennPOS
injection	NN	injection NN PennPOS
of	IN	of pp-f NUPOS
5	CD	5 crd NUPOS
mg/kg	NN	mg/kg NN PennPOS
bleomycin	NN	bleomycin NN PennPOS
A5	NN	A5 NN PennPOS
into	IN	into pp NUPOS
the	DT	the dt NUPOS
specific	JJ	specific JJ PennPOS
pathogen-free	JJ	pathogen-free JJ PennPOS
Wistar	NNP	wistar NN PennPOS
male	NN	male NN PennPOS
rats	NNS	rat NNS PennPOS
.	.	. . NUPOS

Pirfenidone	NN	Pirfenidone NN PennPOS
(	(	( ( NUPOS
P	NN	p NN PennPOS
,	,	, , NUPOS
100	CD	100 crd NUPOS
mg/kg	NN	mg/kg NN PennPOS
once	RB	once a-acp NUPOS
daily	JJ	daily JJ PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
prednisone	NN	prednisone NN PennPOS
(	(	( ( NUPOS
H	NN	h NN PennPOS
,	,	, , NUPOS
5	CD	5 crd NUPOS
mg/kg	NN	mg/kg NN PennPOS
once	RB	once a-acp NUPOS
daily	JJ	daily JJ PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
acetylcysteine	NN	acetylcysteine NN PennPOS
(	(	( ( NUPOS
N	NN	n NN PennPOS
,	,	, , NUPOS
4	CD	4 crd NUPOS
mg/kg	NN	mg/kg NN PennPOS
3	CD	3 crd NUPOS
times	NNS	time NNS PennPOS
per	IN	per IN PennPOS
day	NN	day NN PennPOS
)	)	) ) NUPOS
were	VBD	be vbd NUPOS
used	VBN	use VBN PennPOS
to	TO	to p-acp NUPOS
treat	VB	treat VBP PennPOS
the	DT	the dt NUPOS
rat	NN	rat NN PennPOS
model	NN	model NN PennPOS
by	IN	by IN PennPOS
intragastric	JJ	intragastric JJ PennPOS
administration	NN	administration NN PennPOS
for	IN	for c-acp NUPOS
45	CD	45 crd NUPOS
consecutive	JJ	consecutive JJ PennPOS
days	NNS	day n2 NUPOS
,	,	, , NUPOS
respectively	RB	respective av-j NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
normal	JJ	normal JJ PennPOS
rats	NNS	rat NNS PennPOS
without	IN	without IN PennPOS
IPF	NN	IPF NN PennPOS
were	VBD	be vbd NUPOS
used	VBN	use VBN PennPOS
as	IN	as c-acp NUPOS
the	DT	the dt NUPOS
controls	NNS	control NNS PennPOS
.	.	. . NUPOS

After	IN	after c-acp NUPOS
15	CD	15 crd NUPOS
,	,	, , NUPOS
30	CD	30 crd NUPOS
and	CC	and cc NUPOS
45	CD	45 crd NUPOS
days	NNS	day n2 NUPOS
of	IN	of pp-f NUPOS
drug	NN	drug NN PennPOS
treatment	NN	treatment NN PennPOS
,	,	, , NUPOS
lung	NN	lung NN PennPOS
histopathology	NN	histopathology NN PennPOS
was	VBD	be vbd NUPOS
assessed	VBN	assess VBN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
Cav-1	NN	Cav-1 NN PennPOS
was	VBD	be vbd NUPOS
determined	VBN	determine VBN PennPOS
using	VBG	use VBG PennPOS
real-time	JJ	real-time JJ PennPOS
quantitative	JJ	quantitative JJ PennPOS
PCR	NN	pcr NN PennPOS
and	CC	and cc NUPOS
Western	NN	western NN PennPOS
blot	NN	blot NN PennPOS
;	:	; : NUPOS
the	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
tumour	NN	tumour NN PennPOS
necrosis	NN	necrosis NN PennPOS
factor-a	NN	factor-a NN PennPOS
(	(	( ( NUPOS
TNF-a	NN	TNF-a NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
transforming-growth-factor-b1	NN	transforming-growth-factor-b1 NN PennPOS
(	(	( ( NUPOS
TGF-b1	NN	TGF-b1 NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
platelet-derived	JJ	platelet-derived JJ PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
PDGF	NN	PDGF NN PennPOS
)	)	) ) NUPOS
was	VBD	be vbd NUPOS
determined	VBN	determine VBN PennPOS
by	IN	by IN PennPOS
enzyme-linked	JJ	enzyme-linked JJ PennPOS
immunosorbent	JJ	immunosorbent JJ PennPOS
assay	NN	assay NN PennPOS
.	.	. . NUPOS

RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
After	IN	after c-acp NUPOS
15	CD	15 crd NUPOS
,	,	, , NUPOS
30	CD	30 crd NUPOS
and	CC	and cc NUPOS
45	CD	45 crd NUPOS
days	NNS	day n2 NUPOS
of	IN	of pp-f NUPOS
drug	NN	drug NN PennPOS
treatment	NN	treatment NN PennPOS
,	,	, , NUPOS
comparison	NN	comparison NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
three	CD	three crd NUPOS
drug-treated	JJ	drug-treated JJ PennPOS
groups	NNS	group NNS PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
model	NN	model NN PennPOS
group	NN	group NN PennPOS
showed	VBD	show VBN PennPOS
significantly	RB	significant av-j NUPOS
lower	JJR	low JJR PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.05	CD	0.05 CD PennPOS
)	)	) ) NUPOS
significance	NN	significance NN PennPOS
of	IN	of pp-f NUPOS
airsacculitis	NN	airsacculitis NN PennPOS
and	CC	and cc NUPOS
fibrosis	NN	fibrosis NN PennPOS
scores	NNS	score NNS PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
tissues	NNS	tissue NNS PennPOS
,	,	, , NUPOS
as	RB	as a-acp NUPOS
well	RB	well av NUPOS
as	IN	as c-acp NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
TGF-b1	NN	TGF-b1 NN PennPOS
,	,	, , NUPOS
TNF-a	NN	TNF-a NN PennPOS
and	CC	and cc NUPOS
PDGF	NN	PDGF NN PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
the	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
Cav-1	NN	Cav-1 NN PennPOS
was	VBD	be vbd NUPOS
higher	JJR	high JJR PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.05	CD	0.05 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Compared	VBN	compare VBN PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
N	NN	n NN PennPOS
group	NN	group NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
fibrosis	NN	fibrosis NN PennPOS
score	NN	score NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
lower	JJR	low JJR PennPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
protein	NN	protein NN PennPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
Cav-1	NN	Cav-1 NN PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
higher	JJR	high JJR PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
P	NN	p NN PennPOS
group	NN	group NN PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.05	CD	0.05 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Additionally	RB	additional RB PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
Cav-1	NN	Cav-1 NN PennPOS
was	VBD	be vbd NUPOS
negatively	RB	negative av-jn NUPOS
correlated	VBN	correlate VBN PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
airsacculitis	NN	airsacculitis NN PennPOS
and	CC	and cc NUPOS
fibrosis	NN	fibrosis NN PennPOS
scores	NNS	score NNS PennPOS
(	(	( ( NUPOS
r	NN	r NN PennPOS
=	JJ	= JJ PennPOS
-0.506	CD	-0.506 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
;	:	; : NUPOS
r	NN	r NN PennPOS
=	JJ	= JJ PennPOS
-0.676	CD	-0.676 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
)	)	) ) NUPOS
as	RB	as a-acp NUPOS
well	RB	well av NUPOS
as	IN	as c-acp NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
TGF-b1	NN	TGF-b1 NN PennPOS
,	,	, , NUPOS
TNF-a	NN	TNF-a NN PennPOS
and	CC	and cc NUPOS
PDGF	NN	PDGF NN PennPOS
(	(	( ( NUPOS
r	NN	r NN PennPOS
=	JJ	= JJ PennPOS
-0.590	CD	-0.590 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
;	:	; : NUPOS
r	NN	r NN PennPOS
=	JJ	= JJ PennPOS
-0.530	CD	-0.530 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
;	:	; : NUPOS
r	NN	r NN PennPOS
=	JJ	= JJ PennPOS
-0.553	CD	-0.553 CD PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

DISCUSSION	NN	discussion NN PennPOS
AND	CC	and cc NUPOS
CONCLUSION	NN	conclusion NN PennPOS
:	:	: : NUPOS
Pirfenidone	NNP	Pirfenidone NNP PennPOS
,	,	, , NUPOS
prednisone	NN	prednisone NN PennPOS
and	CC	and cc NUPOS
acetylcysteine	NN	acetylcysteine NN PennPOS
can	MD	can vmb NUPOS
inhibit	VB	inhibit VBP PennPOS
airsacculitis	NN	airsacculitis NN PennPOS
and	CC	and cc NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
in	IN	in IN PennPOS
rat	NN	rat NN PennPOS
IPF	NN	IPF NN PennPOS
models	NNS	model NNS PennPOS
,	,	, , NUPOS
which	WDT	which r-crq NUPOS
may	MD	may vmb NUPOS
be	VB	be vbi NUPOS
related	VBN	relate VBN PennPOS
with	IN	with pp NUPOS
enhanced	VBN	enhance VBN PennPOS
caveolin-1	NN	caveolin-1 NN PennPOS
,	,	, , NUPOS
reduced	VBD	reduce VBD PennPOS
TNF-a	NN	TNF-a NN PennPOS
,	,	, , NUPOS
TGF-b1	NN	TGF-b1 NN PennPOS
,	,	, , NUPOS
PDGF	NN	PDGF NN PennPOS
.	.	. . NUPOS

